News

Our Weekly News digest clarifies and condenses the key developments and talking points in life sciences R&D. We identify and summarise the five top stories in quick-read format, so you have a full, clear and balanced picture of the latest advancements spanning diverse therapeutic areas and key development phases.

Proteins, Antibodies & ADCs

Ianalumab Effective for Immune Thrombocytopenia in Phase III

Breyanzi Gets Green Light from FDA for Marginal Zone Lymphoma

Understanding the CGT Investment Landscape: Interview with Sven Kili, Partner, Saisei Ventures

Avenzo Granted Fast Track Designation by FDA for Bispecific ADC

Tissue Engineering and Stem Cell Development: Insights from a Cell 2025 Roundtable

Navigating Regulatory Considerations for Cell and Gene Therapies: Insights from a Cell 2025 Roundtable

Proteins, Antibodies & ADCs

Ailux Partner with Lilly in $345m Deal to Advance Bispecific Antibody Development

Caribou Announces Positive Data for Off-the-Shelf CAR T

Designing Next Generation Biomaterials: Peptide Hydrogels for Culture, Printing & Regeneration

MIT Develop New Method of AAV Manufacture for Gene Therapy

Proteins, Antibodies & ADCs

GSK Acquires Rights to ADC for Prostate Cancer for £268m

Gene Therapy Delivers Lasting Immune Protection to 59 Children with ADA-SCID

COVID Vaccines Mount Anti-Cancer Immune Response, Say Researchers in Boost for Universal Cancer Vaccine

Proteins, Antibodies & ADCs

See Antibody Binding in 3D: How Cryo-EM Epitope Mapping Accelerates Antibody Discovery

Bristol Myers Squibb Buys Orbital Therapeutics in $1.5b Deal

Proteins, Antibodies & ADCs

Boehringer Ingelheim to Enter $991 Million Partnership with AimedBio for ADC Targeting Broad Spectrum of Cancers

Three CGT Draft Guidance Documents Released by the FDA

Proteins, Antibodies & ADCs

Strategic Decisions in Early R&D for Antibody Research & Discovery: A Forward-Looking Perspective

Proteins, Antibodies & ADCs

Clinical Challenges in the Application of Cell Engagers: Current Hurdles and Future Horizons

mRNA Allergy Vaccine ‘A Potential Breakthrough for Millions’, says Nobel Laureate

Proteins, Antibodies & ADCs

Engineering the Future of ADCs: Innovation, Efficacy, and Clinical Integration

Analysis of Neuropeptide Function Using New Tool